Arnie Oronsky, Ph.D. is a founder and board member of Centrexion Therapeutics. Arnie currently serves as a general partner and managing director at InterWest Partners LLC, a venture capital firm. Earlier in his career, Arnie led pharmaceutical research as vice president for discovery research for the Lederle Laboratories division of American Cyanamid Company. He is a board member of Applied Genetic Technologies Corporation, Drais Pharmaceuticals, Dynavax Technologies, EpicentRx, Integrated Diagnostics, PMV Pharma, Potenza Therapeutics, Sera Prognostics, TESARO and Tizona Therapeutics. Arnie holds a B.A. degree from New York University, a Ph.D. in Immunology from Columbia University and is a senior lecturer at Johns Hopkins Medical School.